[Results from an open trial with naproxen in chronic polyarthritis and other rheumatic diseases].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007592:Joint Diseases / Q000188:drug therapy; D007719:Knee Joint; D008297:Male; D008738:Methyl Ethers / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D009281:Naphthalenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D010003:Osteoarthritis / Q000188:drug therapy*; D011422:Propionates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012785:Shoulder Joint
D008738:Methyl Ethers; D009281:Naphthalenes; D011422:Propionates
Ergebnisse eines offenen Versuches mit Naproxen bei Polyarthritis chronica und anderen Erkrankungen des rheumatischen Formenkreises.